Rheumatic heart valve disease is the most important cardiovascular diseases in young African people. It’s a cause of a heavy morbidity and mortality. The aim of this study is to evaluate the morbidity and mortality of valve surgery in young adults. It was a retrospective and monocentric study over 2 years. We had evaluated 69 patients with an average age of 32 years [16-63years]. Epidemiological, clinical, paraclinical, interventional and post interventional data were collected from archived patient records. The processing of this data was treated by SPSS v 16 and Excel software. Stage III dyspnea was the main symptom. Risk factors for postoperative mortality were cardiac insufficiency (p=0.006) and aortic valve position (p=0.009). Postoperative complications were dominated by hemodynamic instability (23%), pulmonary complications (20%) and infectious complications (3%). Postoperative mortality was 5.8%. Our late mortality was 2.9%.Two cases of minor accidents to anticoagulation drugs were noted. The evolution was favorable for 85.5% of patients. In Africa, rheumatic heart disease remains the most common valvular heart disease with high morbidity and mortality. Cardiac surgery when it is available improves the quality of life of patients. The high cost of this surgery makes it’s not always available. The prophylaxis of streptococcal bacterial attacks remains the best way for prevention.
Published in | International Journal of Cardiovascular and Thoracic Surgery (Volume 4, Issue 1) |
DOI | 10.11648/j.ijcts.20180401.13 |
Page(s) | 10-13 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2018. Published by Science Publishing Group |
Morbidity, Mortality, Cardiac Surgery, Rheumatism Heart Disease
[1] | Monsuez. J. Valvulopathies Rhumatismales. AMC Pratique, 2011; 200 (4): 28-31. |
[2] | Roudaut. R., Dijos. M., Arsac. F., Reant. P., Lafitte S. Pathologie valvulaire: 50 ans de progrès AMC pratique, 2011; 200 (3): 21-23. |
[3] | Essop MR., Nkomo V. T. Rheumatic and NonrheumaticValvular Heart Disease Epidemiology, Management, and Prevention in Africa. Circulation, 2005; 112 (9): 3584-91. |
[4] | Lee J. W., Park NH; Shoo SJ; Jo MS; Song H; Song MG. Surgical Outcome of the Maze Procedure for Atrial Fibrillation in Mitral Valve Disease: Rheumatic Versus Degenerative. The Annals of Thoracic Surgery, 2003; 75 (5): 57-6. |
[5] | Mbaye A.; Pessinaba S; Bodian M; Ndiaye MB; Mbaye F; Kane A; Diao M. La fibrillation atriale, fréquence; facteurs étiologiques, évolution et traitement dans un service de cardiologie de Dakar, Sénégal. Pan African Medical Journal, 2010; 6, 16 (11): 1-11. |
[6] | Antunes M. J. Pulmonary Hypertension in Valve Disease: A beast of the past? The Journal of Thoracic and Cardiovascular Surgery, 2016; 151 (2): 1300-1. |
[7] | Cannesson M., Bastien O., Lehot J. J. Particularités de la prise en charge hémodynamique après chirurgie cardiaque. Réanimation, 2005; 14 (9): 216-24. |
[8] | Aubert S., Praschker B. L., Coignard E., Gandjbakhch I. La plastie mitrale dans tous ses états. MT cardio, 2008; 4 (6): 291-296. |
[9] | Antunes M. J. DeVegaAnnuloplasty of the Tricuspid Valve: Operative Techniques. Thoracic and Cardiovascular Surgery, 2003; 8, 4 (8): 169-76. |
[10] | Chassot P. G., Bovi M., Mustaki J. P. Complications après chirurgie cardiaque. Précis d’anesthésie cardiaque, 2012; 23 (65): 1-65. |
[11] | Samiei N; Hakimi MR; Peighambari MM; Alizadeh-Ghavidel A; Hossein S. Surgical outcomes of heart valves replacement: A study of tertiary specialied cardiac center. ARYA Atheroscler, 2014; 10 (5): 233-7. |
[12] | Carapetis J. R; Powers JR; Currie BJ; Sangster JF; Begg A; Fisher DA; Kilburn CJ; Borrow JNC. Outcomes of Cardiac Valve Replacement for Rheumatic Heart Disease in Aboriginal Australians. Asia Pacific Heart J, 1999; 8, 3 (10): 138-47. |
[13] | Alizzi A. M., Knight J. L., Tully P. J. Surgical challenges in rheumatic heart disease in the Australian indigenous population. Heart, Lung and Circulation, 2010; 19 (4): 295-8. |
[14] | Kangah M. K; Souaga AK; Amani KA; Kiroua-Kamenan YA; Katche KE; Meneas GC; Kendja KF. La chirurgie valvulaire itérative en Afrique: indications, résultats et facteurs de risque. Chirurgie Thoracique Cardio-Vasculaire, 2010; 15 (4): 93-6. |
[15] | Chapelon C., Raguin G., Ziza J. M., Piette J. C., Godeau P. Endocardites infectieuses sur prothèses valvulaires. La revue de médecine interne, 1987; 8 (10): 362-71. |
[16] | Clouet J., Simon H., Sellal O., Grimandi G., Duveau D. Le point sur les prothèses valvulaires. Phram Hosp, 2006; 41, 165 (15): 109-23. |
APA Style
Ciss Amadou Gabriel, Diop Momar Sokhna, Sow Ndeye Fatou, Ba Pape Salmane, Diagne Papa Amath, et al. (2018). Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal. International Journal of Cardiovascular and Thoracic Surgery, 4(1), 10-13. https://doi.org/10.11648/j.ijcts.20180401.13
ACS Style
Ciss Amadou Gabriel; Diop Momar Sokhna; Sow Ndeye Fatou; Ba Pape Salmane; Diagne Papa Amath, et al. Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal. Int. J. Cardiovasc. Thorac. Surg. 2018, 4(1), 10-13. doi: 10.11648/j.ijcts.20180401.13
AMA Style
Ciss Amadou Gabriel, Diop Momar Sokhna, Sow Ndeye Fatou, Ba Pape Salmane, Diagne Papa Amath, et al. Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal. Int J Cardiovasc Thorac Surg. 2018;4(1):10-13. doi: 10.11648/j.ijcts.20180401.13
@article{10.11648/j.ijcts.20180401.13, author = {Ciss Amadou Gabriel and Diop Momar Sokhna and Sow Ndeye Fatou and Ba Pape Salmane and Diagne Papa Amath and Diatta Souleymane and Gaye Magaye and Leye Mohamed and Sene Etienne Birame and Dieng Papa Adama and Ndiaye Assane and Ndiaye Mouhamadou}, title = {Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal}, journal = {International Journal of Cardiovascular and Thoracic Surgery}, volume = {4}, number = {1}, pages = {10-13}, doi = {10.11648/j.ijcts.20180401.13}, url = {https://doi.org/10.11648/j.ijcts.20180401.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20180401.13}, abstract = {Rheumatic heart valve disease is the most important cardiovascular diseases in young African people. It’s a cause of a heavy morbidity and mortality. The aim of this study is to evaluate the morbidity and mortality of valve surgery in young adults. It was a retrospective and monocentric study over 2 years. We had evaluated 69 patients with an average age of 32 years [16-63years]. Epidemiological, clinical, paraclinical, interventional and post interventional data were collected from archived patient records. The processing of this data was treated by SPSS v 16 and Excel software. Stage III dyspnea was the main symptom. Risk factors for postoperative mortality were cardiac insufficiency (p=0.006) and aortic valve position (p=0.009). Postoperative complications were dominated by hemodynamic instability (23%), pulmonary complications (20%) and infectious complications (3%). Postoperative mortality was 5.8%. Our late mortality was 2.9%.Two cases of minor accidents to anticoagulation drugs were noted. The evolution was favorable for 85.5% of patients. In Africa, rheumatic heart disease remains the most common valvular heart disease with high morbidity and mortality. Cardiac surgery when it is available improves the quality of life of patients. The high cost of this surgery makes it’s not always available. The prophylaxis of streptococcal bacterial attacks remains the best way for prevention.}, year = {2018} }
TY - JOUR T1 - Morbidity and Mortality of Rheumatic Valvulopathy Surgery in Young Adults in Senegal AU - Ciss Amadou Gabriel AU - Diop Momar Sokhna AU - Sow Ndeye Fatou AU - Ba Pape Salmane AU - Diagne Papa Amath AU - Diatta Souleymane AU - Gaye Magaye AU - Leye Mohamed AU - Sene Etienne Birame AU - Dieng Papa Adama AU - Ndiaye Assane AU - Ndiaye Mouhamadou Y1 - 2018/02/08 PY - 2018 N1 - https://doi.org/10.11648/j.ijcts.20180401.13 DO - 10.11648/j.ijcts.20180401.13 T2 - International Journal of Cardiovascular and Thoracic Surgery JF - International Journal of Cardiovascular and Thoracic Surgery JO - International Journal of Cardiovascular and Thoracic Surgery SP - 10 EP - 13 PB - Science Publishing Group SN - 2575-4882 UR - https://doi.org/10.11648/j.ijcts.20180401.13 AB - Rheumatic heart valve disease is the most important cardiovascular diseases in young African people. It’s a cause of a heavy morbidity and mortality. The aim of this study is to evaluate the morbidity and mortality of valve surgery in young adults. It was a retrospective and monocentric study over 2 years. We had evaluated 69 patients with an average age of 32 years [16-63years]. Epidemiological, clinical, paraclinical, interventional and post interventional data were collected from archived patient records. The processing of this data was treated by SPSS v 16 and Excel software. Stage III dyspnea was the main symptom. Risk factors for postoperative mortality were cardiac insufficiency (p=0.006) and aortic valve position (p=0.009). Postoperative complications were dominated by hemodynamic instability (23%), pulmonary complications (20%) and infectious complications (3%). Postoperative mortality was 5.8%. Our late mortality was 2.9%.Two cases of minor accidents to anticoagulation drugs were noted. The evolution was favorable for 85.5% of patients. In Africa, rheumatic heart disease remains the most common valvular heart disease with high morbidity and mortality. Cardiac surgery when it is available improves the quality of life of patients. The high cost of this surgery makes it’s not always available. The prophylaxis of streptococcal bacterial attacks remains the best way for prevention. VL - 4 IS - 1 ER -